Virus News and Research

Latest Virus News and Research

Circumcision lowers bacterial load, possibly allowing for HIV infection risk reduction, researchers say

"Circumcision reduces a man's risk of acquiring and transmitting HIV and other sexually transmitted diseases, and now researchers have found a possible explanation: the procedure reduces the quantity and diversity of bacteria at the head of the penis," the New York Times' "Well" blog reports (Bakalar, 4/18).

20 Apr 2013

Research shows respiratory syncytial virus can be transferred during pregnancy to unborn baby

The most common cause of lower respiratory tract infections in infants and young children, respiratory syncytial virus (RSV), can be transferred during pregnancy to an unborn baby, according to Cleveland Clinic Children's Hospital research published online this week in the journal PLOS ONE.

19 Apr 2013

BGU, FCCC receive NIH grant to study role of microRNAs in maintaining measles virus persistence

American Associates, Ben-Gurion University of the Negev announces that Ben-Gurion University of the Negev and Fox Chase Cancer Center in Philadelphia have received a two-year National Institutes of Health research grant to observe "the role of host encoded microRNAs in the maintenance of the measles virus persistent state."

19 Apr 2013

Nature reports on efforts to vaccinate Nigeria's nomadic communities against polio

"A 25-year, $10 billion global effort has taken the number of polio cases from hundreds of thousands per year to just hundreds, but it is now struggling to stamp the virus out of its final strongholds in Pakistan, Afghanistan and Nigeria, where transmission has never been interrupted," Nature reports.

19 Apr 2013

International research team casting wide net in search for H7N9 source, transmission routes

"Another case of bird flu has been reported in China, taking the total infection count to 83 people, as health authorities inside and outside the country try to determine how to stop its spread," CNN reports.

19 Apr 2013

Women with HIV who breastfeed exclusively longer than 4 months have lower risk of transmitting virus to infants, study shows

"The amount of HIV in an infected mother's breast milk spikes when weaning begins, according to a study published [Wednesday] in Science Translational Medicine," Nature reports.

19 Apr 2013

SynCon universal H1N1 influenza vaccine generates protective antibody levels in phase 1 study

Inovio Pharmaceuticals, Inc. announced today that its SynCon universal H1N1 influenza vaccine generated protective antibody levels comparable to a current FDA-approved seasonal influenza vaccine against a currently circulating influenza strain.

19 Apr 2013

Romark Laboratories starts NT-300 Phase 3 trial for treatment of acute uncomplicated influenza

Romark Laboratories announced that it has begun enrolling patients in a global Phase 3 clinical trial of NT-300 (nitazoxanide) for treatment of acute uncomplicated influenza.

19 Apr 2013

Global experts highlight strategies to immunize more children

In advance of World Immunization Week, global experts are highlighting strategies to further advance progress on the Global Vaccine Action Plan that was endorsed by the World Health Assembly, 2012.

19 Apr 2013

Ribavirin, interferon-alpha 2b inhibit virus replication in cell culture, NIH study finds

National Institutes of Health scientists studying an emerging coronavirus have found that a combination of two licensed antiviral drugs, ribavirin and interferon-alpha 2b, can stop the virus from replicating in laboratory-grown cells.

19 Apr 2013

Longer looks: The timely trauma response in Boston; Problems with aging doctors; Transplants from donors with HIV

The bombs at the Boston Marathon were designed to maim and kill, and they did. Three people died within the first moments of the blast. More than a hundred and seventy people were injured. They had their limbs blown off, vital arteries severed, bones fractured, flesh torn open by shrapnel or scorched by the blasts' heat. Yet it now appears that every one of the wounded alive when rescuers reached them will survive.

19 Apr 2013

New assays are effective in managing patients with influenza virus infection

Over 40,000 people die each year in the United States from influenza-related diseases. In patients whose immune systems are compromised, antiviral therapy may be life-saving, but it needs to be initiated quickly. It is therefore crucial to diagnose and type the influenza rapidly.

18 Apr 2013

Health officials have reason to 'remain hypervigilant' over H7N9

"Just as the world was breathing easier about a deadly bird flu virus that killed 371 people over the past decade before dropping out of sight, a different form of bird flu has emerged in China that is causing concern among health experts," a New York Times editorial writes.

18 Apr 2013

H7N9 virus continues to spread; International research team traveling to China to assist

"Two more people in China have died from a new strain of avian influenza, bringing to 16 the number of deaths from the H7N9 virus, and the government has warned that the number of infections could rise," Reuters reports.

18 Apr 2013

Findings hold promise for development of therapies to fight different viral infections

The human body has the ability to ward off viruses by activating a naturally occurring protein at the cellular level, setting off a chain reaction that disrupts the levels of cholesterol required in cell membranes to enable viruses to enter cells.

18 Apr 2013

IDRI, Medicago announce positive Phase I clinical trial results for avian flu pandemic vaccine

IDRI, a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today reported positive interim results from a Phase I clinical trial for an H5N1 Avian Influenza VLP vaccine candidate.

18 Apr 2013

Research findings could lead to novel approaches for eliminating reservoirs of HIV-1

Researchers at Albert Einstein College of Medicine of Yeshiva University have discovered how the protein that blocks HIV-1 from multiplying in white blood cells is regulated.

18 Apr 2013

Tacere Therapeutics submits TT-034 clinical trial application to Recombinant DNA Advisory Committee

RNAi-based therapeutics company Benitec Biopharma Limited today announced that the company's wholly owned US subsidiary, Tacere Therapeutics Inc., has submitted an application to the US National Institutes of Health's Recombinant DNA Advisory Committee.

18 Apr 2013

Research shows how climate, environmental changes influence spread of dangerous viruses

How are human and animal diseases in general affected by the climate becoming "wilder, wetter and warmer"? Solveig Jore's doctoral research shows that the tick Ixodes ricinus has spread over larger geographical areas in Norway and that climate and environmental changes, access to host animals and demography affect tick distribution in Norway.

17 Apr 2013

Antiretroviral therapy does not affect resting energy expenditure in HIV-infected women

Studies have shown that about 10 percent of men infected with human immunodeficiency virus have an elevated resting energy expenditure.

17 Apr 2013

Virus News and Research

Latest Virus News and Research

Circumcision lowers bacterial load, possibly allowing for HIV infection risk reduction, researchers say

Research shows respiratory syncytial virus can be transferred during pregnancy to unborn baby

BGU, FCCC receive NIH grant to study role of microRNAs in maintaining measles virus persistence

Nature reports on efforts to vaccinate Nigeria's nomadic communities against polio

International research team casting wide net in search for H7N9 source, transmission routes

Women with HIV who breastfeed exclusively longer than 4 months have lower risk of transmitting virus to infants, study shows

SynCon universal H1N1 influenza vaccine generates protective antibody levels in phase 1 study

Romark Laboratories starts NT-300 Phase 3 trial for treatment of acute uncomplicated influenza

Global experts highlight strategies to immunize more children

Ribavirin, interferon-alpha 2b inhibit virus replication in cell culture, NIH study finds

Longer looks: The timely trauma response in Boston; Problems with aging doctors; Transplants from donors with HIV

New assays are effective in managing patients with influenza virus infection

Health officials have reason to 'remain hypervigilant' over H7N9

H7N9 virus continues to spread; International research team traveling to China to assist

Findings hold promise for development of therapies to fight different viral infections

IDRI, Medicago announce positive Phase I clinical trial results for avian flu pandemic vaccine

Research findings could lead to novel approaches for eliminating reservoirs of HIV-1

Tacere Therapeutics submits TT-034 clinical trial application to Recombinant DNA Advisory Committee

Research shows how climate, environmental changes influence spread of dangerous viruses

Antiretroviral therapy does not affect resting energy expenditure in HIV-infected women

A new way of characterising biomolecules eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in